Top

Reactions Weekly

Published in:

01-12-2020 | Shingles | Case report

Benralizumab

Herpes zoster infection and thrombocytopenia following off label use : 2 case reports

Published in: Reactions Weekly | Issue 1/2020

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Aalbers A, et al. Benralizumab in refractory hypereosinophilic syndrome effectively reduces eosinophil counts but does not always resolveall clinical symptoms. Allergy 75 (Suppl.): 65, Aug 2020. Available from: URL: http://doi.org/10.1111/all.14504 [abstract]

Title: Benralizumab
Herpes zoster infection and thrombocytopenia following off label use : 2 case reports
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keywords: Shingles
Thrombocytopenia
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-87513-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Benralizumab

Herpes zoster infection and thrombocytopenia following off label use : 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Antineoplastics

Ruxolitinib

Immune globulin

Antineoplastics

Glucocorticoids

Desmopressin